AB0382 A single-site, investigator initiated, open-label trial of the adrenocorticotropic hormone (acth) analogue h.p. acthar gel (repository corticotropin injection) among subjects with moderately to severely active systemic lupus erythematosus (sle)

Abstract

BackgroundSystemic lupus erythematosus (SLE) is a serious systemic disease which left untreated or inadequately treated may have a substantial effect on the morbidity and mortality of the individuals who are...